EC Number | Cloned (Comment) | Organism |
---|---|---|
2.7.1.36 | DNA and amino acid sequence determination and anaylsis, overexpression in a procyclic form of Trypanosoma brucei, and expression of His-tagged wild-type enzyme in Escherichia coli strain BL21(DE3), and of His-tagged selenomethionine-labeled enzyme in Escherichia coli strain B834 | Leishmania major |
2.7.1.36 | DNA and amino acid sequence determination and anaylsis, overexprssion in a procyclic form of Trypanosoma brucei | Trypanosoma brucei |
2.7.1.36 | expression in Trypanosoma brucei | Leishmania major |
EC Number | Crystallization (Comment) | Organism |
---|---|---|
2.7.1.36 | free enzyme and in complex with mevalonate, 1.75 A and 1.9 A resolution, respectively. The mevalonate binds in a deep cavity lined by highly conserved residues. His25 is key for binding and for discrimination of (R)- over (S)-mevalonate, with the main chain amide interacting with the C3 hydroxyl group of (R)-mevalonate, and the side chain contributing, together with Val202 and Thr283, to the construction of a hydrophobic binding site for the C3 methyl substituent. The C5 hydroxyl, where phosphorylation occurs, points towards catalytic residues, Lys18 and Asp155 | Leishmania major |
2.7.1.36 | purified recombinant wild-type and selenomethionine-labeled enzyme as apoenzyme and in complex with (R)-mevalonate, hanging drop vapor diffusion method, 0.002 ml of 7.5 mg/ml protein in 10 mM Tris-HCl, pH 8.5, 20 mM NaCl, and 1 mM DTT, in presence of 3-25 mM adenosine 5'-(beta,gamma-imino)triphosphate, 6-50 mM (R)-mevalonate, 10 mM Mg2+, mixing with reservoir solution containing 1.15 M sodium citrate, pH 6.2, 18°C, X-ray diffraction structure determination and analysis at 1.75-1.9 A resolution, single-wavelength anomalous dispersion, molecular replacement fails | Leishmania major |
EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
2.7.1.36 | Mg2+ | - |
Leishmania major |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.7.1.36 | ATP + (R)-mevalonate | Trypanosoma brucei | - |
ADP + (R)-5-phosphomevalonate | - |
r | |
2.7.1.36 | ATP + (R)-mevalonate | Leishmania major | - |
ADP + (R)-5-phosphomevalonate | - |
r |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.7.1.36 | Leishmania major | - |
- |
- |
2.7.1.36 | Leishmania major | Q4Q6K7 | - |
- |
2.7.1.36 | Trypanosoma brucei | - |
- |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
2.7.1.36 | recombinant His-tagged enzyme from Escherichia coli strain BL21(DE3) by nickel affinity chromatography, dialysis, and anion exchange chromatography to homogeneity | Leishmania major |
EC Number | Reaction | Comment | Organism | Reaction ID |
---|---|---|---|---|
2.7.1.36 | ATP + (R)-mevalonate = ADP + (R)-5-phosphomevalonate | catalytic reaction mechanism, substrate binding structure involves key residue His25 in a deep cavity lined by highly conserved residues, Lys18, Asp155, Val202, and Thr283 are involved in catalysis | Leishmania major |
EC Number | Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|---|
2.7.1.36 | additional information | - |
development of a highly sensitive radioactive assay | Leishmania major |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.7.1.36 | ATP + (R)-mevalonate | - |
Trypanosoma brucei | ADP + (R)-5-phosphomevalonate | - |
r | |
2.7.1.36 | ATP + (R)-mevalonate | - |
Leishmania major | ADP + (R)-5-phosphomevalonate | - |
r |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
2.7.1.36 | 30 | - |
assay ta | Leishmania major |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
2.7.1.36 | 7 | - |
assay at | Leishmania major |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
2.7.1.36 | ADP | - |
Trypanosoma brucei | |
2.7.1.36 | ADP | - |
Leishmania major | |
2.7.1.36 | ATP | - |
Trypanosoma brucei | |
2.7.1.36 | ATP | helix alpha2 and the preceding polypeptide adopt a conformation impeding access to the nucleotide triphosphate binding site suggesting that a conformational rearrangement is required to allow ATP binding, the ATP binding structure is distinct from related enzymes, overview | Leishmania major |